Why the study?
Recent studies suggest 18F-NaF microcalcification may be more sensitive than 18F-FDG-PET for atherogenic changes, motivating a review of both tracers in atherosclerosis and other vascular disorders.
PET imaging with 18F-FDG and 18F-NaF provides valuable molecular insights into arterial inflammation and microcalcification for the early assessment of atherosclerosis and other vascular disorders.
Hypothesis-generating for 18F-NaF PET in atherosclerosis; prospective trials needed before clinical adoption.
Positron emission tomography (PET) imaging with 18F-fluorodeoxyglucose (FDG) represents a method of detecting and characterizing arterial wall inflammation, with potential applications in the early assessment of vascular disorders such as atherosclerosis. By portraying early-stage molecular changes, FDG-PET findings have previously been shown to correlate with atherosclerosis progression. In addition, recent studies have suggested that microcalcification revealed by 18F-sodium fluoride (NaF) may be more sensitive at detecting atherogenic changes compared to FDG-PET. In this review, we summarize the roles of FDG and NaF in the assessment of atherosclerosis and discuss the role of global assessment in quantification of the vascular disease burden. Furthermore, we will review the emerging applications of FDG-PET in various vascular disorders, including pulmonary embolism, as well as inflammatory and infectious vascular diseases.
No takes yet. Share an insight, caveat, or question.
Raynor et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: